Sam-A Pharm. Co. Ltd Cash Flow Conversion Efficiency

Latest as of December 2025: 0.001x

Sam-A Pharm. Co. Ltd cash flow conversion efficiency. Based on the latest financial reports, Sam-A Pharm. Co. Ltd (009300) has a cash flow conversion efficiency ratio of 0.001x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩162.42 Million ≈ $110.07K USD) by net assets (₩228.11 Billion ≈ $154.59 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Sam-A Pharm. Co. Ltd (2009–2025)

Cash flow conversion efficiency of Sam-A Pharm. Co. Ltd from 2009 to 2025. This chart illustrates how Sam-A Pharm. Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Sam-A Pharm. Co. Ltd share price for real-time trading data and today's change.

Sam-A Pharm. Co. Ltd Cash Flow Conversion Ratio Explained

Sam-A Pharm. Co. Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Sam-A Pharm. Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Sam-A Pharm. Co. Ltd ranked by their cash flow conversion efficiency. Also see market cap of Sam-A Pharm. Co. Ltd for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
G8 Education Ltd AU:GEM	0.097x
Choong Ang Vaccine Laboratory Co. Ltd KQ:072020	0.053x
Impulse Fitness Solutions SA PA:MLIFS	N/A
Nahar Industrial Enterprises Limited NSE:NAHARINDUS	0.143x
AmanahRaya Real Estate Investment Trust KLSE:5127	0.006x
Cheche Group Inc. Class A Ordinary Shares NASDAQ:CCG	-0.012x
Aldoro Resources Ltd AU:ARN	-0.048x
NPC Co. Ltd KO:004250	0.040x

Annual Cash Flow Conversion Efficiency for Sam-A Pharm. Co. Ltd (2009–2025)

The table below shows the annual cash flow conversion efficiency of Sam-A Pharm. Co. Ltd from 2009 to 2025. Review Sam-A Pharm. Co. Ltd free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩228.11 Billion ≈ $154.59 Million	₩10.72 Billion ≈ $7.27 Million	0.047x	-59.04%
2024-12-31	₩219.98 Billion ≈ $149.07 Million	₩25.25 Billion ≈ $17.11 Million	0.115x	+10.83%
2023-12-31	₩200.47 Billion ≈ $135.86 Million	₩20.76 Billion ≈ $14.07 Million	0.104x	-4.59%
2022-12-31	₩180.62 Billion ≈ $122.40 Million	₩19.60 Billion ≈ $13.29 Million	0.109x	+44.26%
2021-12-31	₩172.02 Billion ≈ $116.58 Million	₩12.94 Billion ≈ $8.77 Million	0.075x	+32.98%
2020-12-31	₩166.29 Billion ≈ $112.69 Million	₩9.41 Billion ≈ $6.38 Million	0.057x	-28.04%
2019-12-31	₩168.15 Billion ≈ $113.95 Million	₩13.22 Billion ≈ $8.96 Million	0.079x	-0.82%
2018-12-31	₩160.90 Billion ≈ $109.04 Million	₩12.76 Billion ≈ $8.64 Million	0.079x	+142.87%
2017-12-31	₩156.10 Billion ≈ $105.79 Million	₩5.10 Billion ≈ $3.45 Million	0.033x	-53.85%
2016-12-31	₩148.92 Billion ≈ $100.92 Million	₩10.53 Billion ≈ $7.14 Million	0.071x	-8.33%
2015-12-31	₩140.08 Billion ≈ $94.93 Million	₩10.81 Billion ≈ $7.32 Million	0.077x	-9.06%
2014-12-31	₩134.15 Billion ≈ $90.91 Million	₩11.38 Billion ≈ $7.71 Million	0.085x	-26.49%
2012-12-31	₩121.33 Billion ≈ $82.22 Million	₩14.00 Billion ≈ $9.49 Million	0.115x	+21.89%
2011-12-31	₩110.58 Billion ≈ $74.94 Million	₩10.47 Billion ≈ $7.10 Million	0.095x	+89.49%
2010-12-31	₩101.99 Billion ≈ $69.12 Million	₩5.10 Billion ≈ $3.45 Million	0.050x	+147.91%
2009-12-31	₩79.92 Billion ≈ $54.16 Million	₩-8.33 Billion ≈ $-5.65 Million	-0.104x	--

About Sam-A Pharm. Co. Ltd

KQ:009300 Korea Pharmaceuticals

Market Cap

$56.13 Million

₩82.82 Billion KRW

Market Cap Rank

#21246 Global

#1242 in Korea

Share Price

₩13570.00

Change (1 day)

+0.30%

52-Week Range

₩12130.00 - ₩17080.00

All Time High

₩36150.00